Metabolic surgery significantly lowered risk for major adverse liver outcomes vs. nonsurgical management among patients with obesity and compensated cirrhosis from metabolic dysfunction-associated ...

Reports Q4 revenue $103.3M, consensus $97.81M. Bill Sibold, Chief Executive Officer of Madrigal, stated, “Looking back on 2024, I’m incredibly ...

Madrigal Pharmaceuticals (MDGL) reported positive two-year results from the open-label compensated MASH cirrhosis arm of the Phase 3 ...

Bariatric surgery reduces the progression to decompensated cirrhosis and the risk for major adverse liver outcomes, such as ...

The global rise in obesity and type 2 diabetes is fueling an epidemic of MASLD and MASH, now recognized as the leading cause ...

The following is a summary of “Role of multifocal visual evoked potential in detection of minimal hepatic encephalopathy in ...

Insilico achieved preclinical milestone in its collaboration with Therasid Bioscience, a South Korean based biotechnology company focuses on developing innovative first-in-class drugs for treatment ...

Fecal microbiota transplant, regardless of dose or route, was safe and associated with reduced hepatic encephalopathy ...

THIRUVANANTHAPURAM: Cirrhosis, previously associated with alcohol consumption, is now becoming more common among non-drinkers ...

Right before her adoption, Piper, a senior Yorkie, suffered liver failure. She was rushed to the ER and is now receiving the ...

Weight-Loss Surgery Lowers Risk of Developing Complications of Liver Disease in Patients With Cirrhosis and Obesity Jan. 27, 2025 — A study shows that patients with obesity and fatty liver ...

A new approach combining immunotherapy, radiation, and surgery enabled successful liver cancer removal in a high-risk patient ...